Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: A randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women

European Journal of Clinical Investigation

Volumn 33, Issue 1, 2003, Pages 41-50

  Rejnmark, Lars ^a,b   Vestergaard, P ^a,b   Pedersen, A R ^b   Heickendorff, L ^a   Andreasen, F ^b   Mosekilde, L ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Bone; Calcitrol; Diuretics; Humans; Osteopenia; Parathyroid hormones

Indexed keywords

ALKALINE PHOSPHATASE; BENDROFLUMETHIAZIDE; BUMETANIDE; CALCITRIOL; CALCIUM ION; LOOP DIURETIC AGENT; OSTEOCALCIN; PARATHYROID HORMONE; THIAZIDE DIURETIC AGENT;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HORMONE BLOOD LEVEL; HUMAN; OSSIFICATION; OSTEOPENIA; PH; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ALKALINE PHOSPHATASE; BENDROFLUMETHIAZIDE; BIOLOGICAL MARKERS; BONE DISEASES, METABOLIC; BUMETANIDE; CALCIUM; CROSS-OVER STUDIES; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HOMEOSTASIS; HUMANS; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0037221776     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01103.x     Document Type: Article

References (45)

1. Steiniche T, Mosekilde L, Christensen MS, Melsen F. Histomorphometric analysis of bone in idiopathic hypercalciuria before and after treatment with thiazide. APMIS 1989;97:302-8.
2. Coe FL, Parks JH. New insights into the pathophysiology and treatment of nephrolithiasis: New research venues. J Bone Miner Res 1997;12:522-33.
3. Jones G, Nguyen T, Sambrook PN, Eisman JA. Thiazide diuretics and fractures: Can meta-analysis help? J Bone Miner Res 1995;10:106-11.
4. Cauley JA, Cummings SR, Seeley DG, Black D, Browner W et al. Effects of thiazide diuretic therapy on bone mass, fractures, and falls. The Study Osteoporotic Fractures Res Group Ann Intern Med 1993;118:666-73.
5. LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000;133:516-26.
6. Reid IR, Ames RW, Orr-Walker BJ, Clearwater JM, Horne AM et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: A randomized controlled trial. Am J Med 2000;109:362-70.
7. Lamberg BA, Kuhlbäck B. Effect of chlorothiazide and hydrochlorothiazide on the excretion of calcium in urine. Scand J Clin Lab Invest 1959;11:351-7.
8. Elmgreen J, Tougaard L, Leth A, Christensen MS. Elevated serum parathyroid hormone concentration during treatment with high ceiling diuretics. Eur J Clin Pharmacol 1980;18:363-4.
9. Stein MS, Scherer SC, Walton SL, Gilbert RE, Ebeling PR et al. Risk factors for secondary hyperparathyrodism in a nursing home population. Clin Endocrinol Oxf 1996;44(4):375-83.
10. Reichel H, Deibert B, Geberth S, Schmidt GH, Ritz E. Furosemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency. Nephrol Dial Transplant 1992;7:8-15.
11. Goulding A, Spears GFS, Simpson FO. Effects of different diuretics on urinary calcium excretion in a general population. Aust N Z J Med 1978;8:474-8.
12. Fujita T, Chan JCM, Bartter FC. Effects of oral furosemide and salt loading on parathyroid function in normal subjects. Nephron 1984;38:109-14.
13. Gabow PA, Hanson TJ, Popovtzer MM, Schrier RW. Furosemide-induced reduction in ionized calcium in hypoparathyroid patients. Ann Intern Med 1977;86:579-81.
14. Coe FL, Canterbury JM, Firpo JJ, Reiss E. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest 1973;52:134-42.
15. Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: A randomized controlled study. J Intern Med 2001;250:144-53.
16. Ooms ME, Lips P, Van Lingen A, Valkenburg HA. Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly women. J Bone Miner Res 1993;8:669-75.
17. Heidrich FE, Stergachis A, Gross KM. Diuretic drug use and the risk for hip fracture. Ann Intern Med 1991;115:1-6.
18. Tromp AM, Ooms ME, Popp-Snijders C, Roos JC, Lips P. Predictors of fractures in elderly women. Osteoporos Int 2000;11:134-40.
19. Rashiq S, Logan RFA. Role of drugs in fractures of the femoral neck. BMJ 1986;292:861-3.
20. Cumming RG, Klineberg RJ. Psychotropics, thiazide diuretics and hip fractures in the elderly. Med J Aust 1993;158:414-7.
21. Fleiss JL. The crossover study. In: Fleiss JL, editor. The Design and Analysis of Clinical Experiments. New York: John Wiley & Sons; 1986.pp.263-90.
22. Bijvoet OL, Morgan DB, Fourman P. The assessment of phosphate reabsorption. Clin Chim Acta 1969;26:15-24.
23. Rosenquist C, Qvist P, Bjarnason N, Christiansen C. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem 1995;41:1439-45.
24. Hanson DA, Weis MA, Bollen AM, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251-8.
25. Thode J, Fogh AN, Wimberley PD, Moller S, Siggaard AO. Relation between pH and ionized calcium in vitro and in vivo in man. Scand J Clin Lab Invest Suppl 1983;165:79-82.
26. Zerwekh JE, Pak CY. Selective effects of thiazide therapy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias. Metabolism 1980;29:13-7.
27. Ljunghall S, Backman U, Danielson BG, Fellström B, Johansson G, Wikström B. Calcium and magnesium metabolism during long-term treatment with thiazides. Scand J Urol Nephrol 1981;15:257-62.
28. Lian JB, Stein GS, Canalis E, Robey PG, Boskey AL. Bone formation: Osteoblast lineage cells, growth factors, matrix proteins, and the miniralization process. In: Favus MJ.Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Philadelphia: Lippincott Williams & Wilkins;1999:14-29.
29. Wilcox CS.Diuretics: In the Kidney. In: Brenner BM, editor. Philadelphia: W.B. Saunders; 1996. pp.2299-330.
30. Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 1989;36:682-9.
31. Knauf H, Mutschler E. Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy. Eur J Clin Pharmacol 1993;44(Suppl. 1):S63-S68.
32. Reyes AJ. Effects of diuretics on renal excretory function. Eur Heart J 1992;13(Suppl. G):15-21.
33. Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women. Eur J Clin Invest 2001;31:764-72.
34. Suki WN, Yium JJ, Von Minden m Saller-herbert C, Eknoyan G, Martinez-Maldonado M. Acute treatment of hypercalcemia with furosemide. N Engl J Med 1970;283:836-40.
35. Pylypchuk G, Ehrig U, Wilson DR. Effect of hydrochlorothiazide on urine saturation with brushite, in vitro collagen calcification by urine, and urinary inhibitors of collagen calcification. Can Med Assoc J 1978;118:792-6.
36. Reyes AJ. Effects of diuretics on outputs and flows of urine and urinary solutes in healthy subjects. Drugs 1991;41(Suppl. 3):35-59.
37. Cohen L, Kitzes R, Shnaider H. The myth of long-term thiazide-induced magnesium deficiency. Magnesium 1985;4:176-81.
38. Davies DL, Fraser R. Do diuretics cause magnesium deficiency? Br J Clin Pharmacol 1993;36:1-10.
39. Dorup I, Skajaa K, Thybo NK. Oral magnesium supplementation restores the concentrations of magnesium, potassium and sodium-potassium pumps in skeletal muscle of patients receiving diuretic treatment. J Intern Med 1993;233:117-23.
40. Quamme GA. Renal magnesium handling: New insights in understanding old problems. Kidney Int 1997;52:1180-95.
41. Zofkova I, Kancheva RL. The relationship between magnesium and calciotropic hormones. Magnes Res 1995;8:77-84.
42. Krejs GJ, Nicar MJ, Zerwekh JE, Norman DA, Kane MG, Pak CY. Effect of 1,25-dihydroxyvitamin D3 on calcium and magnesium absorption in the healthy human jejunum and ileum. Am J Med 1983;75:973-6.
43. Brickman AS, Massry SG, Coburn JW. Changes in serum and urinary calcium during treatment with hydrochlorothiazide: Studies on mechanisms. J Clin Invest 1972;51:945-54.
44. Suki WN, Hull AR, Rector FCJ, Seldin DW. Mechanism of the effect of thiazide diuretics on calcium and uric acid. Clin Res 1967;15:78.
45. Frost HM. Transient-steady state phenomena in microdamage physiology: A proposed algorithm for lamellar bone. Calcif Tissue Int 1989;44:367-81.